Welcome to our dedicated page for Zoetis SEC filings (Ticker: ZTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Zoetis Inc. filings document the animal health company's operating results, capital returns, financing activity and governance disclosures. Recent 8-K reports furnish quarterly and annual financial results, guidance, dividend declarations, investor presentations and other Regulation FD disclosures.
The company's proxy materials address board and compensation matters, including executive pay and equity-award disclosures. Other filings record its New York Stock Exchange-listed common stock and debt financing, including a private offering of convertible senior notes, related indenture terms and capped call transactions.
FULLER JULIE reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Julie Fuller received a grant of 669.3367 Phantom Stock Units tied to Zoetis common stock. These units were awarded at a reference value of $38.2000 per unit under the Zoetis Supplemental Savings Plan and are settled in cash after she leaves the company.
Following this award, Fuller holds a total of 1247.3931 Phantom Stock Units. Each unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically account for around 5% of each unit’s value, so the unit value tracks the Zoetis share price and these cash-equivalent holdings.
Joseph Wetteny reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Chief Financial Officer Joseph Wetteny received a grant of 2,114.7557 phantom stock units on Zoetis common stock. The award was made at a reference value of $38.20 per unit under the Zoetis Supplemental Savings Plan.
Following this grant, Wetteny holds a total of 8,918.3552 phantom stock units. Each phantom stock unit tracks the market value of Zoetis common stock plus a small portion of cash-equivalent investments, and is settled in cash after his separation from service. The award currently corresponds to 712.6923 underlying shares of Zoetis common stock.
Zoetis Inc. Chief Executive Officer Kristin C. Peck received a grant of 4,391.2607 Phantom Stock Units at a reference price of $38.20 per unit. Following this award, she holds a total of 62,802.0367 Phantom Stock Units.
Each Phantom Stock Unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically account for around 5% of the unit’s total value. These units were acquired under the Zoetis Supplemental Savings Plan and will be settled in cash after her separation from service.
Driscoll Rimma reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Rimma Driscoll received a grant of 641.7440 phantom stock units on Zoetis common stock at a reference value of $38.2000 per unit. Following this award, she holds a total of 6009.5487 phantom stock units.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically make up around 5% of the unit’s total value. These units are settled in cash after her separation from service and may be reallocated among plan investment funds subject to Zoetis’ transfer rules.
Esch Kevin reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Kevin Esch received a grant of 219.9529 phantom stock units on Zoetis common stock. The award, valued using a reference price of $38.20 per unit, increased his holdings to 496.9909 phantom stock units, representing an economic interest tied to Zoetis shares.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically account for around 5% of the unit’s total value. These units are settled in cash after Esch’s separation from service, with 74.1262 underlying common shares linked to this particular grant.
Zoetis Inc. Executive Vice President Ferran Astorga Jeannette received a grant of 593.1735 Phantom Stock Units on Zoetis common stock, valued at $38.20 per unit. Each unit represents a fraction of a phantom share plus cash-equivalent investments, referencing Zoetis’ market value.
The grant corresponds to 199.9050 underlying shares of common stock, bringing the executive’s total Phantom Stock Units to 2,245.8327. These units, acquired under the Zoetis Supplemental Savings Plan, are cash-settled after separation from service and may be reallocated among investment funds subject to Zoetis’ transfer limits.
Zoetis Inc. Executive Vice President Keith Sarbaugh received a grant of 626.6723 phantom stock units on Zoetis common stock. Each phantom stock unit was valued at $38.20 and corresponds to 211.1944 underlying shares of common stock. Following this grant, his phantom stock unit balance is 1,874.4329 units. These units were acquired under the Zoetis Supplemental Savings Plan and are settled in cash after his separation from service, with value tied to Zoetis’ share price and a small portion in cash-equivalent investments.
Lagano Roxanne reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Roxanne Lagano received a grant of 1,266.4405 phantom stock units under the Zoetis Supplemental Savings Plan. Each unit’s value is tied to Zoetis common stock plus a small cash-equivalent component, and units are settled in cash after separation from service.
The grant represents an economic interest equivalent to 426.8022 shares of Zoetis common stock, with a reference value of $38.2000 per phantom stock unit. Following this award, Lagano holds a total of 30,081.5721 phantom stock units, which remain subject to plan transfer and investment rules.
Zoetis Inc. Schedule 13G/A amendment shows The Vanguard Group reports no beneficial ownership of Zoetis common stock. The filing, labeled Amendment No. 11, explains an internal realignment effective January 12, 2026 that led certain Vanguard subsidiaries to report holdings separately. The filing states 0 shares beneficially owned and 0% of the class, and is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026. The issuer address is listed as 10 Sylvan Way, Parsippany, NJ.
Zoetis Inc. director Mark Stetter reported receiving a grant of 215.5358 phantom stock units linked to Zoetis common stock. These units were acquired under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan as a deferral of his cash retainer fees into the Zoetis stock fund, including dividend equivalents. Each phantom stock unit represents one share of Zoetis common stock but will be settled in cash after his separation from service, so this is a compensation and deferral event rather than an open-market stock purchase or sale.